Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice
Geng‐Ruei Chang, Hsien-Yueh Liu, Wei‐Cheng Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6680-6680
Open Access | Times Cited: 17

Showing 17 citing articles:

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice
Geng‐Ruei Chang, Weili Lin, Tzu-Chun Lin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11383-11383
Open Access | Times Cited: 39
Evaluation of various scoring systems as predictors of the need for intensive care unit admission and other adverse outcomes among patients with acute clozapine poisoning
Heba Lashin, Asmaa Fady Sharif
Toxicology Research (2023) Vol. 12, Iss. 3, pp. 468-479
Closed Access | Times Cited: 13
Drug Repurposing for Non-Alcoholic Fatty Liver Disease by Analyzing Networks Among Drugs, Diseases, and Genes
Md. Altaf-Ul-Amin, Ahmad Kamal Nasution, Rumman Mahfujul Islam, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 255-255
Open Access
Zinc sulphate attenuates metabolic dysfunctions induced by olanzapine via the reduction of insulin resistance, hepatic oxidative stress, and inflammation in albino rats
Samir A. E. Bashandy, Rasha E. Mostafa, Marawan A. Elbaset, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
Wenying Yi, Haibo Wu, Weibin Fu, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 841-849
Open Access | Times Cited: 3
Development and validation of a risk prediction nomogram for disposition of acute clozapine intoxicated patients to intensive care unit
Asmaa Fady Sharif, HA Aouissi, Zeinab A. Kasemy, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 7
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao, Xiuzhi Wang, Qianqian Ma, et al.
Chinese Herbal Medicines (2022) Vol. 14, Iss. 3, pp. 367-375
Open Access | Times Cited: 9
Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
Zhiyong Gao, Meihong Xiu, Jiahong Liu, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Small-interfering RNA targeting proprotein convertase subtilisin/kexin type 9 might promote fatty liver disease and hepatocellular carcinoma through upregulation of CD36
Frank S. Fan
Tumor Biology (2023) Vol. 45, Iss. 1, pp. 73-80
Open Access | Times Cited: 4
Association between blood chromium and hepatic steatosis assessed by liver ultrasound transient elastography: National Health and Nutrition Examination Survey 2017–2020
Yingying Xiang, Ruonan Zhou, Ziwei Wang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Curcumin Improved Glucose Intolerance, Renal Injury, and Nonalcoholic Fatty Liver Disease and Decreased Chromium Loss through Urine in Obese Mice
Geng‐Ruei Chang, Wen‐Tsong Hsieh, Lan-Szu Chou, et al.
Processes (2021) Vol. 9, Iss. 7, pp. 1132-1132
Open Access | Times Cited: 10
Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice
Geng‐Ruei Chang, Po‐Hsun Hou, Chao‐Ming Wang, et al.
Veterinary Sciences (2021) Vol. 8, Iss. 9, pp. 189-189
Open Access | Times Cited: 7
The role of alcohol intake in the pharmacogenetics of treatment with clozapine
Nancy Monroy‐Jaramillo, José Jaime Martínez‐Magaña, Blanca Estela Pérez-Aldana, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 6, pp. 371-392
Closed Access | Times Cited: 4
The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders - a review
Jakub Rogalski, Aleksandra Subdys, Oliwia Gawlik-Kotelnicka
Current Problems of Psychiatry (2022) Vol. 23, Iss. 3, pp. 128-143
Open Access | Times Cited: 4
Molecular Mechanisms of Clozapine-Induced Pancreatic Damage and its Modulation by L-Carnitine in a Rat Model
Dalia Mesallam, Eman Ahmed Alaa El-Din, Mai Said Ibrahim, et al.
Egyptian Society of Clinical Toxicology Journal (2024) Vol. 12, Iss. 1, pp. 182-199
Open Access
Clozapine impaired glucose-stimulated insulin secretion partly by increasing plasma 5-HT levels due to the inhibition of OCT1-mediated hepatic 5-HT uptake in mice
Wen-han Wu, Hao Zhi, Wenke Feng, et al.
Acta Pharmacologica Sinica (2024)
Closed Access
The Preventive Effect of Zinc Sulfate against Olanzapine-Induced Testicular Toxicity in Male Rats
Hossam Ebaid, Samir A. E. Bashandy, Iftekhar Hassan, et al.
Biological Trace Element Research (2024)
Open Access
Zinc sulphate alleviates olanzapine-induced testicular oxidative stress and alters trace elements in male rats
Hossam Ebaid, Samir A. E. Bashandy, Iftekhar Hassan, et al.
Research Square (Research Square) (2024)
Open Access
HFD-exacerbated Metabolic Side Effects of Olanzapine Are Suppressed by ER Stress Inhibitor
Yu-feng Zuo, Baohua Zhang, Ming-rui Guo, et al.
Current Medical Science (2023) Vol. 43, Iss. 6, pp. 1116-1132
Closed Access
Page 1

Scroll to top